Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terlipressin vs. Octreotide for Renal Function in Cirrhotic Patients with Acute Variceal Bleeding
NCT04028323Phase 4Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Jul 2019
- Primary completion
- Jul 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of terlipressin in nephropathy, Variceal bleeding, sponsored by Nanfang Hospital, Southern Medical University. Status: unknown.
02
Drugs
terlipressin
03
Conditions
nephropathyVariceal bleeding
Beyond the preview
Go deeper on NCT04028323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04028323.